Stocktoria
UCB SA UCB.BR
UCB SA (UCB.BR) earns a Piotroski F-score of 9/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.53% (safety: safe). FY2025 revenue was €7.7B at a 20.1% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 36 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 9/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.091 |
| Retained earnings / assets | 0.478 |
| EBIT / assets | 0.11 |
| Equity / liabilities | 1.49 |
FAQ
Is UCB.BR financially healthy?
UCB SA's Piotroski F-score is 9/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does UCB.BR pay a dividend, and is it safe?
Yes. UCB SA pays a dividend yielding about 0.53% with a 16.9% payout ratio, rated “safe” for safety.
How profitable is UCB.BR?
In FY2025, UCB SA had a net margin of 20.1% and a return on equity of 14.3%.
Source: company filings via Yahoo Finance · BE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.